381 471

Cited 0 times in

우리나라 말기 신부전 환자의 신장이식과 신장혈액투석과의 비용-효용 분석

DC FieldValueLanguage
dc.contributor.author김명수-
dc.contributor.author김순일-
dc.contributor.author김유선-
dc.date.accessioned2015-04-23T17:46:51Z-
dc.date.available2015-04-23T17:46:51Z-
dc.date.issued2010-
dc.identifier.issn1598-1711-
dc.identifier.urihttps://ir.ymlib.yonsei.ac.kr/handle/22282913/103118-
dc.description.abstractBackground: The purpose of this study was to examine the cost-effectiveness of renal transplantation and hemodialysis among end-stage renal disease patients. Methods: Empirical data on treatment costs were collected from five hospitals in Korea. We used European Renal Association-European Dialysis and Transplant Association registry data for transition probability. Quality adjusted life year (QALY) values were derived from the literature. A Markov model was used for predicting the cost utility of transplantation and hemodialysis over a 10-year period. Results: Renal transplantation was less costly and resulted in a better outcome than hemodialysis. The cost per QALY gained was 19,450 thousand won in transplantation patients, whereas it was 36,514 thousand won per QALY gained in hemodialysis patients. Conclusions: Although the cost of the first year after transplantation was expensive, transplantation was more effective over 2 years and was less costly than hemodialysis. The results suggest that transplantation is more cost-effective than hemodialysis in Korea.-
dc.description.statementOfResponsibilityopen-
dc.formatapplication/pdf-
dc.relation.isPartOfJournal of the Korean Society for Transplantation (대한이식학회지)-
dc.rightsCC BY-NC-ND 2.0 KR-
dc.rights.urihttps://creativecommons.org/licenses/by-nc-nd/2.0/kr/-
dc.title우리나라 말기 신부전 환자의 신장이식과 신장혈액투석과의 비용-효용 분석-
dc.title.alternativeA Renal Transplantation and Hemodialysis Cost-Utility Analysis in Patients with End-Stage Renal Disease-
dc.typeArticle-
dc.contributor.collegeCollege of Medicine (의과대학)-
dc.contributor.departmentDept. of Surgery (외과학)-
dc.contributor.googleauthor김순일-
dc.contributor.googleauthor김유선-
dc.contributor.googleauthor이후연-
dc.contributor.googleauthor함명일-
dc.contributor.googleauthor손선영-
dc.contributor.googleauthor전경옥-
dc.contributor.googleauthor박은철-
dc.contributor.googleauthor김명수-
dc.identifier.doi10.4285/jkstn.2010.24.3.173-
dc.admin.authorfalse-
dc.admin.mappingfalse-
dc.contributor.localIdA00649-
dc.contributor.localIdA00785-
dc.contributor.localIdA00424-
dc.relation.journalcodeJ01858-
dc.subject.keywordCost-effectiveness analysis-
dc.subject.keywordCost-utility analysis-
dc.subject.keywordRenal transplantation-
dc.subject.keywordHemodialysis-
dc.subject.keywordEnd-stage renal disease (ESRD)-
dc.contributor.alternativeNameKim, Myoung Soo-
dc.contributor.alternativeNameKim, Soon Il-
dc.contributor.alternativeNameKim, Yu Seun-
dc.contributor.affiliatedAuthorKim, Soon Il-
dc.contributor.affiliatedAuthorKim, Yu Seun-
dc.contributor.affiliatedAuthorKim, Myoung Soo-
dc.citation.volume24-
dc.citation.number3-
dc.citation.startPage173-
dc.citation.endPage181-
dc.identifier.bibliographicCitationJournal of the Korean Society for Transplantation, Vol.24(3) : 173-181, 2010-
Appears in Collections:
1. College of Medicine (의과대학) > Dept. of Surgery (외과학교실) > 1. Journal Papers

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.